A study on 19,372 patients with immune-mediated inflammatory diseases, including inflammatory bowel disease (IBD), RA, spondyloarthropathies, psoriasis, and psoriatic arthritis, examined whether obesity affects response to anti-TNF agents. Here, TNF is linked to psoriatic arthritis.